List of insiders holdings for eFFECTOR Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Locust Walk Sponsor LLC 10% Owner | 2021-08-27 18:31:16 | 7,567,500 0 | 7,567,500 | Form 4 |
| Carlyle Group Inc. Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner | 2023-08-18 16:16:55 | 4,829,891 0 | 4,829,891 | Form 13D |
| Locust Walk Partners LLC 10% Owner | 2021-01-14 19:46:17 | 0 4,511,250 | 4,511,250 | Form 4 |
| Presidio Management Group X LLC US VENTURE PARTNERS X LP USVP X AFFILIATES LP Tansey Casey M ROOT JONATHAN D 10% Owner | 2022-08-18 20:04:12 | 4,480,578 0 | 4,480,578 | Form 13D |
| Gandhi Mayank Chief Business Officer | 2023-01-19 17:04:30 | 150,000 0 | 150,000 | Form 4 |
| McNulty Alana B. Chief Business Officer | 2022-06-22 16:19:51 | 150,000 0 | 150,000 | Form 4 |
| Patel Premal Chief Medical Officer | 2022-01-24 20:05:36 | 150,000 0 | 150,000 | Form 4 |
| WORLAND STEPHEN T Chief Executive Officer | 2024-02-21 16:56:05 | 80,000 0 | 80,000 | Form 4 |
| Lasky Laurence Director | 2021-10-08 17:12:48 | 40,000 0 | 40,000 | Form 4 |
| Byrnes Michael Chief Financial Officer | 2024-02-21 17:02:32 | 40,000 0 | 40,000 | Form 4 |
| Abingworth LLP 10% Owner | 2021-12-17 16:30:28 | 0 40,000 | 40,000 | Form 4 |
| ATWOOD BRIAN G Director | 2021-01-14 19:45:35 | 0 25,000 | 25,000 | Form 4 |
| Warner Douglas J Chief Medical Officer | 2024-02-21 17:00:03 | 25,000 0 | 25,000 | Form 4 |
| Geffken Daniel E. Chief Financial Officer | 2021-01-14 19:49:38 | 0 20,000 | 20,000 | Form 4 |
| Smither John W Director | 2023-06-22 20:16:58 | 20,000 0 | 20,000 | Form 4 |
| Kosacz Barbara Director | 2021-01-14 19:50:46 | 0 17,500 | 17,500 | Form 4 |
| Gallagher Brian M. Jr. Director | 2024-02-21 17:15:32 | 2000 0 | 2000 | Form 4 |
| Harrington-Smith Kristen Director | 2024-02-21 17:20:37 | 2000 0 | 2000 | Form 4 |
| Klencke Barbara Director | 2024-02-21 17:22:39 | 2000 0 | 2000 | Form 4 |
| Ehrlich Christopher B Director | 2024-02-21 17:25:25 | 2000 0 | 2000 | Form 4 |
| Bhatt Elizabeth Director | 2024-02-21 17:27:10 | 2000 0 | 2000 | Form 4 |
| Loewy Caroline M Director | 2024-02-21 17:39:55 | 2000 0 | 2000 | Form 4 |
| SR ONE CAPITAL MANAGEMENT LLC SR One Capital Fund I Aggregator LP SR ONE CAPITAL PARTNERS I LP SR One Co-Invest I LLC SR One Co-Invest I Manager LLC George Simeon 10% Owner | 2024-02-09 20:14:29 | 0 0 | 0 | Form 13G |
| Column Group II GP LP Svennilson Peter COLUMN GROUP II LP GOEDDEL DAVID V 10% Owner | 2023-11-22 16:16:55 | 0 0 | 0 | Form 13D |